Upcoming

Apply to Internal Competition // Limit: 4 // Tickets Available: 4

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Limiting Language
Applications are limited to four per institution per receipt date including new (A0), resubmissions (A1) and renewal (T2); NCI-designated cancer center consortia are considered one institution. NCI seeks a broad representation of institutions for this award mechanism and may take this into account when making funding decisions.

Purpose
Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for the Research Specialist Award in any area of NCI-funded clinical cancer research. This NOFO is specifically for clinician scientists to continue to participate in the NCI clinical trials networks through leadership in the 1) development of national clinical trials, 2) implementation of NCI clinical trials in their institutions, and 3) national service to the NCI clinical trials networks through participation in the scientific review committees, monitoring committees, and other activities, but not serve as principal investigators of research project grants. These clinician scientists are vital to sustaining the NCI-funded clinical trials enterprise. The Research Specialist Award is intended to provide stable support for clinician scientists at their institutions for significant leadership and exceptional participation in the NCI-sponsored clinical trials networks that conduct cancer treatment, prevention and control, and care delivery clinical trials. NCI-sponsored clinical trials networks include but are not limited to the National Clinical Trials Network (NCTN), the NCI Community Oncology Research Program (NCORP), the Experimental Therapeutics Clinical Trials Network (ETCTN), and the Cancer Prevention Clinical Trials Network (CP-CTNet).

The Research Specialist Award is designed to encourage the development of a career path for cancer clinical trial investigators who provide leadership, participation, and scientific support for the NCI clinical trials networks at their institutions and within those networks. This leadership includes the development of concepts and protocols for clinical trials, participation in scientific steering committees and network committees, and accrual to NCI-sponsored clinical trials. The institutional activities may include the implementation of cancer clinical trials including participation in the review of safety data, monitoring the conduct and progress of open clinical trials, and serving on institutional review committees. These activities are necessary for the successful conduct of NCI-sponsored cancer clinical trials. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others or other sources of funding for cancer research career continuity.

Apply to Internal Competition // Limit: 3 // Tickets Available: 3

Limiting Language:

Each PPP is limited to a maximum of four PIs. No university shall exceed leading three PPPs. Candidate must be a University Consortium Member prior to submitting a Notice of Intent (NOI)

Topics: 

1. TOPIC 1: IMPROVED SUB-SCALE HYPERSONIC AIR-BREATHING PROPULSION TEST CAPABILITIES  
2. TOPIC 2: DIGITAL TWIN ARCHITECTURE FOR HYPERSONIC AIR-BREATHING SYSTEM AND MISSION DESIGN TRADE STUDIES
3. TOPIC 3: SHOCK PROPERTIES OF ADDITIVELY MANUFACTURED MATERIALS (AMM)
4. TOPIC 4: EXPERIMENTAL & MODEL BASED ENDOTHERMIC FUEL PROPERTIES
5. TOPIC 5: CERAMIC TESTING FOR HYPERSONIC VEHICLES
6. TOPIC 6: MITIGATION OF THERMAL DEGRADATION IN HYPERSONIC WINDOWS
7. TOPIC 7: NETWORKING AND COLLABORATIVE COMMUNICATIONS 

Questions regarding the Project Call may be emailed to UCAH@tamu.edu through September 5, 2025 at 5:00 PM EST. Answers to the questions will be posted on the UCAH website for this RPP Project Call. All questions and answers will be made available to all proposers, unless they involve proprietary or CUI material. 

Apply to internal competition // Limit: 2* // Tickets Available: 2

*The first submission may address any cancer type. A second submission is allowed but only for a translational or clinical stage project that primarily focuses on one of the following four cancer types: upper GI, glioblastoma, triple-negative breast cancer, or pancreatic cancer.

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Purpose of the Award
The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts. Basic, translational, and clinical projects are eligible. The project must seek to address an overarching, urgent scientific question. We welcome projects addressing substantial unmet needs in any type of cancer. We particularly encourage teams with innovative ideas for therapeutic strategies for upper GI, glioblastoma, triple-negative breast cancer, and pancreatic cancer to consider applying in this round.

Request Ticket // Limit: 1 // Tickets Available: 1 

Limiting Language
Only one application is allowed.

Executive Summary
The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), invites grant applications for Education and Research Centers (ERCs) that are focused on occupational safety and health (OSH) training. NIOSH is mandated to provide an adequate supply of qualified personnel to carry out the purposes of the Occupational Safety and Health Act, and the ERCs are one of the primary means for meeting this mandate.

ERCs are academic institutions that provide high-quality interdisciplinary graduate and post-graduate training, research training, continuing education, and outreach in the core OSH disciplines of industrial hygiene, occupational health nursing, occupational medicine, and occupational safety, as well as allied disciplines.

Research and research training are integral components of ERCs, with ERC faculty and NIOSH trainees conducting research on issues related to the NIOSH National Occupational Research Agenda (NORA) and emerging issues to advance the OSH field.

NIOSH ERCs have regional presence to ensure that the training and research they support is beneficial to workers across the nation.

ERCs serve as resources for our nation's workforce through continuing education, outreach and strong collaboration with professional associations, worker advocacy groups, businesses, industries, and public health agencies. ERCs work with other institutions and organizations, including Minority Serving Institutions and other NIOSH supported training programs to have a positive impact on worker health, safety, and well-being.

Limit: 1 // Tickets Available: 0

K. Huntoon (Neurosurgery)

For the V Foundation V Scholar Grant 2025 funding opportunity, the University of Arizona Cancer Center (UACC) can nominate one applicant.

For more information please contact: UACC-PreAward.

Purpose of Award:

The UACC is seeking nominations for the V Scholar Grant call which supports adult cancer research. This award supports tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research. Emphasis for this grant mechanism is on supporting exceptional early career investigators at the Assistant Professor stage to be better positioned to leverage large R01 or similar sustaining grants.

Research on ANY adult cancer type will be funded in this call. Research areas not included in this scope are epidemiology, behavioral science, and health services research.

Applicant Eligibility:

Nominee must meet all of the following criteria by the nomination due date:

• Nominated by their Cancer Center Director or similar high ranking research official.
• Employed at a non-profit research institution (e.g., 501c3, Section 170).
• Either a US Citizen or a permanent legal resident in the US.
• Possess at least 2 years post-doctoral (MD or PhD) fellowship training. For MDs, a minimum of one year is acceptable if only one year is required for their specialty.
• Clinical scientists are eligible if the research institution demonstrates that it will fully support the research applicant (e.g., dedicated lab space, committed research time, start-up funds).
• Must be in a full-time tenure track or tenured faculty position (for e.g., must be eligible to
  apply for PI status on an R01 at your institution). Non-promotable adjunct, affiliated, temporary, part-time, or acting faculty positions are not eligible for Principal Investigator nomination.
• V Scholar applicants must have been appointed to their first full-time tenure track Assistant Professor position no more than 5 years prior to the nomination due date, and not yet promoted to Associate Professor.
  • Extensions to the 5-year limit may be given on a case-by-case basis to nominees who took parental leave (or other types of leave) during this window. Please contact grants@v.org with the following to obtain approval BEFORE submitting the nomination form:
    • Appointment start date
    • Length of leave
    • Institutional tenure clock stoppages/extensions, if applicable

Four tracks, see limits below: 

• Departmental/Division Transformation Track (DDTT) – No institutional limits on proposals
• Institutional Transformation Track (ITT) - Limit: 1 // Institutionally Coordinated
• Emerging Faculty Research Track (EFRT) – U of A is NOT ELIGIBLE
• HSI Program Resource Hubs (Hubs) – U of A is NOT (currently) ELIGIBLE  

HSI Initiatives must coordinate the submission for the Institutional Transformation Track or future Resource Hubs proposals. If you are interested in this funding opportunity, please contact Riley McIsaac.